V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20217453 | 20082888 | 1.69 | 57.85 | null | null | 2017-03-19 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 101560666 |
| 20217455 | 20082889 | null | null | null | 2018-02-01 | 2018-02-14 | null | null | null | CAPECITABINE + IRINOTECAN | 100146658 |
| 20217457 | 20082890 | 1.73 | 92.2 | Adjuvant (A) | 2016-08-01 | 2016-08-08 | null | null | N | CISPLATIN + ETOPOSIDE | 101152764 |
| 20217458 | 20082891 | 1.75 | 89 | Neo-adjuvant (N) | 2017-01-03 | 2017-01-06 | null | null | Y | CISPLATIN + ETOPOSIDE | 100604904 |
| 20217460 | 20082892 | 1.68 | 55 | Curative (C) | null | 2019-03-09 | null | null | Y | CAPECITABINE + MITOMYCIN + RT | 101335390 |
| 20217463 | 20082894 | null | null | null | null | 2018-01-31 | null | null | null | CISPLATIN + ETOPOSIDE | 101373706 |
| 20217466 | 20082895 | null | null | null | 2018-08-30 | 2018-08-30 | null | null | null | CAPECITABINE + IRINOTECAN | 101295900 |
| 20217468 | 20082896 | 1.64 | 69.7 | Palliative (P) | null | 2016-07-10 | null | null | N | HCX | 101354835 |
| 20217471 | 20082897 | 1.77 | 43 | Adjuvant (A) | 2017-09-29 | 2017-10-03 | CAPECITABINE + IRINOTECAN | 02 | N | CAPECITABINE + IRINOTECAN | 100513603 |
| 20217472 | 20082898 | null | null | null | 2018-07-10 | 2018-07-10 | null | null | null | CISPLATIN + ETOPOSIDE | 101429843 |
| 20217474 | 20082899 | 1.72 | 0 | Palliative (P) | 2017-04-29 | 2017-05-06 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 100411057 |
| 20217476 | 20082901 | null | null | null | null | 2017-02-22 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 101250242 |
| 20217477 | 20082902 | 1.74 | 69.3 | Palliative (P) | 2018-11-13 | 2018-11-19 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + IRINOTECAN + MDG | 101237014 |
| 20217478 | 20082903 | 1.78 | 72.5 | null | null | 2019-06-25 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 100838033 |
| 20217484 | 20082904 | null | null | null | 2019-08-27 | 2019-09-12 | ECF | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100945563 |
| 20217492 | 20082907 | 1.44 | 87.9 | Palliative (P) | 2018-12-15 | 2018-12-21 | null | null | N | LENVATINIB | 100296646 |
| 20217495 | 20082908 | 1.7 | 85 | Palliative (P) | 2019-02-26 | 2019-03-01 | Cape+Cisplatin+Trastuzumab Main | N | N | HCX | 101102625 |
| 20217499 | 20082910 | 1.6 | 71.4 | null | null | 2016-04-22 | null | null | Y | HCX | 101163424 |
| 20217501 | 20082911 | 1.6 | 52.2 | Palliative (P) | 2016-09-27 | 2016-09-27 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100169075 |
| 20217507 | 20082912 | 1.65 | 64 | Palliative (P) | 2017-07-10 | 2017-07-17 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100064648 |
| 20217513 | 20082914 | 1.75 | 58.3 | Adjuvant (A) | 2017-09-30 | 2017-10-05 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100334636 |
| 20217517 | 20082915 | null | null | null | 2018-01-08 | 2018-01-09 | null | null | null | CISPLATIN + ETOPOSIDE | 100533196 |
| 20217520 | 20082916 | 1.56 | 81.3 | null | 2019-02-13 | 2019-02-19 | null | null | Y | CAPECITABINE + IRINOTECAN | 100825938 |
| 20217521 | 20082917 | null | 53.45 | null | 2017-04-03 | 2017-04-03 | LENVATINIB | 02 | null | LENVATINIB | 100052358 |
| 20217532 | 20082918 | 1.64 | 72.8 | Curative (C) | 2019-11-07 | 2019-11-07 | null | null | Y | CAPECITABINE + MITOMYCIN + RT | 100615608 |
| 20217536 | 20082919 | 1.7 | 63.3 | Palliative (P) | null | 2017-05-13 | null | null | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100278628 |
| 20217538 | 20082920 | null | null | null | null | 2016-05-02 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 101009637 |
| 20217540 | 20082921 | null | null | null | 2019-06-16 | 2019-06-18 | CISPLATIN + ETOPOSIDE | 02 | null | CISPLATIN + ETOPOSIDE | 100029413 |
| 20217541 | 20082922 | 1.63 | 82.3 | Palliative (P) | 2018-07-21 | 2018-07-24 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 101278276 |
| 20217542 | 20082923 | 1.76 | 49.2 | Curative (C) | 2019-09-07 | 2019-09-07 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 101585627 |
| 20217543 | 20082924 | 1.64 | 62 | Curative (C) | 2019-08-16 | 2019-08-17 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100024670 |
| 20217546 | 20082926 | 1.52 | null | Palliative (P) | 2018-02-01 | 2018-02-04 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100122822 |
| 20217549 | 20082927 | 1.7 | 72.9 | Palliative (P) | 2019-03-05 | 2019-03-06 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101838665 |
| 20217552 | 20082928 | null | null | null | null | 2017-12-12 | ECarboX | 02 | null | HCX | 101496379 |
| 20217564 | 20082931 | 1.85 | 81 | Neo-adjuvant (N) | 2017-04-29 | 2017-05-13 | null | null | Y | CAPECITABINE + IRINOTECAN | 100828834 |
| 20217567 | 20082934 | null | null | null | null | 2019-04-29 | null | null | null | HCX | 100619721 |
| 20217575 | 20082937 | 1.84 | null | Neo-adjuvant (N) | null | 2016-10-24 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101677541 |
| 20217579 | 20082938 | 1.75 | 84.1 | Palliative (P) | 2018-09-05 | 2018-09-24 | null | null | N | HCX | 100904715 |
| 20217580 | 20082939 | null | null | null | 2016-12-24 | 2016-12-24 | LENVATINIB | 02 | null | LENVATINIB | 100760139 |
| 20217581 | 20082940 | null | null | null | null | 2019-07-17 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101303744 |
| 20217585 | 20082941 | 1.75 | 63.5 | Neo-adjuvant (N) | 2018-06-11 | 2018-06-25 | null | null | Y | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100715681 |
| 20217588 | 20082943 | null | null | null | null | 2019-07-31 | null | null | null | CISPLATIN + ETOPOSIDE | 101310422 |
| 20217590 | 20082944 | 1.93 | 54 | Neo-adjuvant (N) | 2018-02-02 | 2018-02-02 | ECarboX | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100478594 |
| 20217593 | 20082946 | null | null | null | 2017-10-02 | 2017-10-03 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 100792392 |
| 20217594 | 20082947 | 1.56 | 76.9 | Palliative (P) | null | 2017-08-22 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 100818713 |
| 20217595 | 20082948 | null | null | null | 2018-01-12 | 2018-01-12 | ECarboX | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100730039 |
| 20217597 | 20082950 | 1.62 | 77.5 | Neo-adjuvant (N) | null | 2016-12-27 | null | null | null | HCX | 100542302 |
| 20217600 | 20082953 | null | 80.6 | Palliative (P) | 2016-12-01 | 2016-12-10 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101868879 |
| 20217604 | 20082954 | 1.66 | 56 | Palliative (P) | 2018-03-12 | 2018-03-16 | Capecitabine (14 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 101426154 |
| 20217606 | 20082955 | 1.74 | 57 | Palliative (P) | 2016-07-06 | 2016-07-26 | CAPECITABINE + CISPLATIN + Trastuzumab | N | N | HCX | 101774989 |